Kira Pharmaceuticals Revenue and Competitors

Boston, MA USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Kira Pharmaceuticals's estimated annual revenue is currently $6M per year.(i)
  • Kira Pharmaceuticals's estimated revenue per employee is $155,000

Employee Data

  • Kira Pharmaceuticals has 39 Employees.(i)
  • Kira Pharmaceuticals grew their employee count by -2% last year.

Kira Pharmaceuticals's People

NameTitleEmail/Phone
1
VP and Head CMCReveal Email/Phone
2
Head External Alliances and Special Projects, Co-FounderReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.2M67-45%$107.3MN/A
#2
$0.3M20%N/AN/A
#3
$5.1M336%N/AN/A
#4
$11.9M77-37%$312.8MN/A
#5
$0.9M60%N/AN/A
#6
$235M300-5%$340.9MN/A
#7
$45.9M237-7%$7.6MN/A
#8
$3.9M5035%N/AN/A
#9
$5.4M353%N/AN/A
#10
$1.6M100%N/AN/A
Add Company

What Is Kira Pharmaceuticals?

Kira Pharmaceuticals is a global biotechnology company pioneering a new generation of complement-targeted therapies to treat immune-mediated diseases. Enabled by its proprietary LOGIC drug discovery platform, Kira is committed to advancing first-in-class and best-in-class therapies to patients around the world. The company is headquartered in Cambridge, Massachusetts with an R&D center in Suzhou, China.

keywords:N/A

N/A

Total Funding

39

Number of Employees

$6M

Revenue (est)

-2%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Kira Pharmaceuticals News

2022-04-17 - New study reveals emotional and psychological impact of infertility

... partners of infertile patients,” explained Kira Dalgaard, vice president and global head of medical affairs at Ferring Pharmaceuticals.

2022-04-17 - Acrivon Therapeutics Announces the Appointments of Rasmus Holm ...

She previously held positions at Kira Pharmaceuticals, SpringWorks Therapeutics, Purdue Pharma, and Alexion Pharmaceuticals.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$8.4M39-11%N/A
#2
$3M39-22%$77.6M
#3
$3.9M3950%$1.5M
#4
$4.7M39-13%N/A
#5
$7.8M3939%N/A